Heart and Vascular Research

Clinical Trials & Studies

University Hospitals Harrington Heart & Vascular Institute continues to build on a legacy of innovation that began over 150 years ago. Our team is forging medicine’s future by translating cardiovascular advances at the earliest stages of development into improved patient care.

Learn More

To learn more about heart and vascular clinical trials, call 216-844-3130

Our team of more than 70 cardiovascular faculty, fellows and staff manages over 140 active clinical trials and follows more than 3,500 patients. Our trials include first-in-human and Phase II-IV studies in cardiovascular medicine, interventional cardiology, electrophysiology, vascular surgery, endovascular therapies, heart failure, cardiac surgery and advanced cardiovascular imaging.

The following highlights just a few of our actively recruiting clinical trials. These and other University Hospitals Cleveland Medical Center advances are poised to benefit the lives of patients affected by heart and vascular diseases for generations to come.


Clinical effectiveness of body fat distribution imaging in real-world practice

Calcium Score

Studies to address risks for cardiovascular disease

Champion-AF Study

A study to evaluate the safety of atrial fibrillation treatment

Continuous Glucose Monitoring Device Study

Patient Registry Sub-Study Consent: Feasibility and Clinical Utility of the Dexcom in CINEMA Program Patients

with diabetes

Evaluating metabolic mechanisms of Ertugliflozin in diabetes & heart failure

EMMED without diabetes

Evaluating Metabolic Mechanisms of Ertugliflozin in Non-Diabetes Heart Failure with Preserved Ejection Fraction

Renal Denervation (SPYRAL)

Clinical research study to evaluate the potential benefits of an investigative device-based intervention to help lower blood pressure

Vascular Innovation Unit (VIU)

The Vascular Innovation Unit (VIU) focuses on being the first to bring the latest limb salvage techniques to our patients before anywhere else. Innovative limb salvage clinical trials are underway at University Hospitals Cleveland Medical Center.